Discontinued — last reported Q2 '24
Software as a Service — D&A
ResMed Software as a Service — D&A remained flat by 0.0% to $2.56M in Q2 2024 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $2.28M to $2.56M. Over 3 years (FY 2021 to FY 2024), Software as a Service — D&A shows an upward trend with a 25.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate higher capital investment in software infrastructure, while a decrease could suggest aging assets or lower investment levels.
Detailed definition
This metric represents the non-cash expense allocated to the Software as a Service segment for the wear and tear of tang...
Peer comparison
Standard across technology and medical device companies with significant digital service components.
rmd_segment_software_as_a_service_depreciation_and_amortizationHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $5.23M | $7.32M | $9.12M | $10.24M |
| YoY Change | — | +39.9% | +24.7% | +12.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's software as a service — d&a?
- ResMed (RMD) reported software as a service — d&a of $2.56M in Q2 2024.
- How has ResMed's software as a service — d&a changed year-over-year?
- ResMed's software as a service — d&a increased by 12.3% year-over-year, from $2.28M to $2.56M.
- What is the long-term trend for ResMed's software as a service — d&a?
- Over 3 years (2021 to 2024), ResMed's software as a service — d&a has grown at a 25.1% compound annual growth rate (CAGR), from $5.23M to $10.24M.
- What does software as a service — d&a mean?
- The non-cash cost of using up physical and intangible assets within the SaaS business unit.